Government bans replicas of weight loss drug Ozempic, as vision of raid on filthy lab released Wed 22 May 2024 at 5:22am , updated Wed 22 May 2024 at 6:22am The federal government will ban all compounding pharmacists from making replica versions of diabetes drugs like Ozempic and Mounjaro, widely used off-label for weight loss, amid public safety concerns
GH/IGF-1 axis modulation is hypothesized to support neuroplasticity mechanisms
ContractLaboratory.com connects pharmaceutical companies, CROs, and research organizations with accredited pharmacology and drug development testing laboratories and biopharmaceutical specialists
A day after Edgar filed suit in Pennsylvania, a woman named Athalean Harper-Mosley filed a similar suit in California
Endotoxin tested and produced under controlled laboratory conditions for research applications
K RAS Mutation and Epithelial-Macrophage Interplay in Pancreatic Neoplastic Transformation